The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

At the ITF Masters event in Bedford, NS, last month, the Canadians cleaned up by winning almost every title at the Atlantic ...

A Trinity Life Sciences report found that more pharma product launches were successful in 2023 than the year before. Here are ...

Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

A new government program will give pregnant mothers and newborns free access to RSV vaccines, a move that is expected to ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

S hould a high dividend yield raise a yellow flag for investors? In some cases, yes. But not always. There are select stocks ...

Amid current economic uncertainties and market volatility, investing in defensive stocks appears as an ideal strategy for ...

As of last year, RSV vaccination with Abrysvo has been recommended for pregnant women in the United States from 32 to 36 ...